At the University of Rochester, researchers have developed a method to precisely control protein expression using ASOs.
At the University of Rochester, researchers have developed a method to precisely control protein expression using ASOs. By targeting specific mRNAs, they can enhance or suppress protein production, offering a new tool for therapeutic development. The researchers’ innovation has shown success in animal models of heart failure, opening doors to treat diseases like cardiac hypertrophy and organ fibrosis. By providing effective and targeted treatment, this technology has the potential to improve the treatment of other conditions including neurogenerative disorders and rare genetic diseases. The team are seekingpartners to deploy this technology through an exclusive license.